Krystal Biotech Inc.
(KRYS)
undefined
undefined%
At close: undefined
155.81
0.12%
After-hours Jan 06, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | 308.15 | -14.43 | -22.32 | -35.04 | -46.13 | -21.38 | -7.12 | -39.56 |
| PS Ratio | 66.45 | n/a | n/a | n/a | n/a | 226.68 | n/a | n/a |
| PB Ratio | 4.33 | 3.87 | 2.62 | 3.86 | 4.34 | 2.06 | 1.14 | 157.41 |
| P/FCF Ratio | -33.49 | -13.15 | -13.35 | -27.54 | -35.07 | -19.93 | -13.75 | -34.31 |
| P/OCF Ratio | -37.93 | -20.08 | -32.39 | -43.22 | -47.06 | -24.65 | -14.5 | -34.7 |
| OCF/S Ratio | -1.75 | n/a | n/a | n/a | n/a | -9.2 | n/a | n/a |
| Debt / Equity Ratio | n/a | 0.00 | n/a | 0.03 | 0.00 | n/a | n/a | 6.38 |
| Quick Ratio | 17.55 | 13.30 | 17.18 | 17.80 | 58.88 | 43.39 | 77.99 | 50.44 |
| Current Ratio | 17.76 | 13.30 | 17.18 | 17.80 | 58.88 | 43.39 | 77.99 | 50.44 |
| Asset Turnover | 0.06 | n/a | n/a | n/a | n/a | 0.01 | n/a | n/a |
| Interest Coverage | n/a | -27.81 | -45.76 | n/a | n/a | -11.6 | -1.52 | -163.29 |
| Return on Equity (ROE) | 0.01 | -0.27 | -0.12 | -0.11 | -0.09 | -0.1 | -0.16 | -3.98 |
| Return on Assets (ROA) | 0.01 | -0.25 | -0.11 | -0.1 | -0.09 | -0.09 | -0.16 | -0.53 |
| Return on Capital (ROIC) | -0.14 | -0.27 | -0.11 | -0.11 | -0.11 | -0.1 | -0.1 | -0.53 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 93.90% | n/a | n/a | n/a | n/a | 86.27% | n/a | n/a |
| Net Profit Margin | 21.56% | n/a | n/a | n/a | n/a | -1.06K% | n/a | n/a |
| Pretax Profit Margin | 25.44% | n/a | n/a | n/a | n/a | -1.06K% | n/a | n/a |
| Operating Profit Margin | -216.43% | n/a | n/a | n/a | n/a | -1.16K% | n/a | n/a |
| FCF Margin | -198.43% | n/a | n/a | n/a | n/a | -1.14K% | n/a | n/a |
| EBITDA Margin | 35.31% | n/a | n/a | n/a | n/a | -1.05K% | n/a | n/a |